|
1.
|
Hansson LE, Sparen P and Nyren O:
Increasing incidence of both major histological types of esophageal
carcinomas among men in Sweden. Int J Cancer. 54:402–407. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Ozols R: Esophageal cancer. Curr Problems
Cancer. XVIII:191–246. 1994.
|
|
3.
|
Conteduca V, Sansonno D, Ingravallo G,
Marangi S, Russi S, Lauletta G and Dammacco F: Barrett’s esophagus
and esophageal cancer: An overview. Int J Oncol. 41:414–424.
2012.
|
|
4.
|
di Pietro M, Lao-Sirieix P, Boyle S,
Cassidy A, Castillo D, Saadi A, Eskeland R and Fitzgerald RC:
Evidence for a functional role of epigenetically regulated
midcluster HOXB genes in the development of Barrett esophagus. Proc
Natl Acad Sci USA. 109:9077–9082. 2012.PubMed/NCBI
|
|
5.
|
Coia LR: The esophagus. Moss’ Radiation
Oncology: Rationale, Techniques, Results. Cox J: Mosby-Year Book;
St. Louise: pp. 4091994
|
|
6.
|
Follis RH Jr: The pathology of zinc
deficiency. Zinc Metabolism. Prasad AS: Springfield; pp. 129–141.
1966
|
|
7.
|
Taccioli C, Chen H, Jiang Y, Liu XP, Huang
K, Smalley KJ, Farber JL, Croce CM and Fong LY: Dietary zinc
deficiency fuels esophageal cancer development by inducing a
distinct inflammatory signature. Oncogene. 31:4550–4558. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Alder H, Taccioli C, Chen H, Jiang Y,
Smalley KJ, Fadda P, Ozer HG, Huebner K, Farber JL, Croce CM and
Fong LY: Dysregulation of miR-31 and miR-21 induced by zinc
deficiency promotes esophageal cancer. Carcinogenesis.
33:1736–1744. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Kaz AM and Grady WM: Epigenetic biomarkers
in esophageal cancer. Cancer Lett. Mar 7–2012.(Epub ahead of
print).
|
|
10.
|
Shoji M, Ninomiya I, Makino I, Kinoshita
J, Nakamura K, Oyama K, Nakagawara H, Fujita H, Tajima H, Takamura
H, Kitagawa H, Fushida S, Harada S, Fujimura T and Ohta T: Valproic
acid, a histone deacetylase inhibitor, enhances radiosensitivity in
esophageal squamous cell carcinoma. Int J Oncol. 40:2140–2146.
2012.PubMed/NCBI
|
|
11.
|
Roesch A, Fukunaga-Kalabis M, Schmidt EC,
Zabierowski SE, Brafford PA, Vultur A, Basu D, Gimotty P, Vogt T
and Herlyn M: A temporarily distinct subpopulation of slow-cycling
melanoma cells is required for continuous tumor growth. Cell.
141:583–594. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
13.
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: the next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell
LL, Polyak K, Brisken C, Yang J and Weinberg RA: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Reya T, Morrison SJ, Clarke MF and
Weissman IL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Dewi DL, Ishii H, Kano Y, Nishikawa S,
Haraguchi N, Sakai D, Satoh T, Doki Y and Mori M: Cancer stem cell
theory in gastrointestinal malignancies: recent progress and
upcoming challenges. J Gastroenterol. 46:1145–1157. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Chicas A, Kapoor A, Wang X, Aksoy O,
Evertts AG, Zhang MQ, Garcia BA, Bernstein E and Lowe SW: H3K4
demethylation by Jarid1a and Jarid1b contributes to
retinoblastoma-mediated gene silencing during cellular senescence.
Proc Natl Acad Sci USA. 109:8971–8976. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Rayess H, Wang MB and Srivatsan ES:
Cellular senescence and tumor suppressor gene p16. Int J Cancer.
130:1715–1725. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Vurusaner B, Poli G and Basaga H: Tumor
suppressor genes and ROS: complex networks of interactions. Free
Radic Biol Med. 52:7–18. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Schrump DS, Chen GA, Consuli U, Jin X and
Roth JA: Inhibition of esophageal cancer proliferation by
adenovirally mediated delivery of p16INK4. Cancer Gene Ther.
3:357–364. 1996.PubMed/NCBI
|
|
21.
|
Matsubara H, Tagawa M, Gunji Y, Takenaga
K, Sugaya M, Urashima T, Koide Y, Suzuki T, Asano T, Ochiai T,
Isono K, Kageyama H, Nakamura Y and Sakiyama S: Study of
irradiation effects on cytokine secretion from
retrovirally-transduced tumor cells: a model for tumor vaccination.
Anticancer Res. 16:645–650. 1996.PubMed/NCBI
|
|
22.
|
Matsubara H, Koide Y, Sugaya M, Gunji Y,
Asano T, Ochiai T, Takegana K, Sakiyama S and Tagawa M: Antitumor
response of genetically engineered IL-2 expression to human
esophageal carcinoma cells in mature T cell-defective condition.
Int J Oncol. 13:1217–1239. 1998.
|
|
23.
|
Miyauchi M, Shimada H, Kadomatsu K,
Muramatsu T, Matsubara S, Ikematsu S, Takenaga K, Asano T, Ochiai
T, Sakiyama S and Tagawa M: Frequent expression of midkine gene in
esophageal cancer suggests a potential usage of its promoter for
suicide gene therapy. Jpn J Cancer Res. 90:469–475. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Matsubara H, Kawamura K, Sugaya M, Koide
Y, Gunji Y, Takenaga K, Asano T, Ochiai T, Sakiyama S and Tagawa M:
Differential efficacy of suicide gene therapy by herpes simplex
virus-thymidine kinase gene reflects the status of p53 gene in
human esophageal cancer cells. Anticancer Res. 19:4157–4160.
1999.
|
|
25.
|
Yamamoto T, Nakatani M, Narukawa K and
Obika S: Antisense drug discovery and development. Future Med Chem.
3:339–365. 2011. View Article : Google Scholar
|
